SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Citurgia Biochemicals submits financial results

15 Feb 2023 Evaluate
Citurgia Biochemicals has informed that it enclosed Unaudited Financial Results for the Quarter ended on 31st December, 2022 along with Limited Review Report issued by the statutory auditor of the company as approved by the Board of Directors in their meeting held on 14th February, 2023.

The above information is a part of company’s filings submitted to BSE.

Citurgia Biochem Share Price

97.45 -1.95 (-1.96%)
20-Apr-2026 14:09 View Price Chart
Peers
Company Name CMP
BASF India 3663.40
Tata Chemicals 704.40
SRF 2461.45
Pidilite Inds. 1393.60
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×